Proteasome inhibition induces reversible impairments in protein synthesis

FASEB Journal

Volumn 20, Issue 8, 2006, Pages 1055-1063

  Ding, Qunxing ^a   Dimayuga, Edgardo ^a   Markesbery, William R ^a,b   Keller, Jeffrey N ^a,c,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Department of Neurology and Neuropathology ^*

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Alzheimer's disease; Neurodegeneration; Parkinson's disease; Protein aggregation

Indexed keywords

EPOXOMYCIN; MG 115; MG 262; PROTEASOME; PROTEASOME INHIBITOR; CYSTEINE PROTEINASE INHIBITOR;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEOMICS; RAT; ANIMAL; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; CYSTEINE PROTEINASE INHIBITORS; MODELS, BIOLOGICAL; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745977756     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-5495com     Document Type: Article

References (39)

1. Shringarpure, R., and Davies, K. J. (2002) Protein turnover by the proteasome in aging and disease. Free Radic. Biol. Med. 32, 84-8
2. Goldberg, A.L. (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899
3. Chondrogianni, N., and Gonos, E. S. (2005) Proteasome dysfunction in mammalian aging: Steps and factors involved. Exp. Gerontol. 40, 931-938
4. Keller, J. N., Gee, J., and Ding, Q. (2002) The proteasome in brain aging. Ageing Res. Rev. 1, 279-293
5. Keller, J. N., Hanni, K. B., and Markesbery, W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439
6. McNaught, K. S. (2004) Proteolytic dysfunction in neurodegenerative disorders. Int. Rev. Neurobiol. 62, 95-119
7. Seo, H., Sonntag, K.C., and Isacson, O. (2004) Generalized brain and skin proteasome inhibition in Huntington's disease. Ann. Neurol. 56, 319-328
8. Kisselev, A. F., and Goldberg, A. L. (2001) Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8, 739-758
9. Lee, D. H., and Goldberg, A. L. (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403
10. Chondrogianni, N., Stratford, F. L., Trougakos, I. P., Friguet, B., Rivett, A. J., and Gonos, E. S. (2003) Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 278, 28026-28037
11. Stolzing, A., and Grune, T. (2001) The proteasome and its function in the ageing process. Clin. Exp. Dermatol. 26, 566-572
12. Sullivan, P. G., Dragicevic, N. B., Deng, J. H., Bai, Y., Dimayuga, E., Ding, Q., Chen, Q., Bruce-Keller, A. J., and Keller, J. N. (2004) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279, 20699-20707
13. Rideout, H. J., Wang, Q., Park, D. S., and Stefanis, L. (2003) Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J. Neurosci. 23, 1237-1245
14. Rideout, H. J., Larsen, K. E., Sulzer, D., and Stefanis, L. (2001) Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein- immunoreactive inclusions in PC12 cells. J. Neurochem. 78, 899-908
15. Hyun, D. H., Lee, M., Halliwell, B., and Jenner, P. (2003) Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 86, 363-367
16. Halliwell, B. (2002) Hypothesis: proteasomal dysfunction a primary event in neurodegeneration that leads to nitrative and oxidative stress and subsequent neuron death. Ann. N. Y. Acad. Sci. 962, 182-194
17. Kim, T. S., Jang, C. Y., Kim, H. D., Lee, J. Y., Ahn, B. Y., and Kim, J. (2005) Interaction of Hsp90 to ribosomal proteins protects from ubiquitination and proteasome-dependent degradation. Mol. Biol. Cell In press
18. Jiang, H.Y., and Wek, R. C. (2005) Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280, 14189-14202
19. Othumpangat, S., Kashon, M., and Joseph, P. (2005) Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride. J. Biol. Chem. 280, 25162-25169
20. Rattan, S. I. (1996) Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31, 33-47
21. Rattan, S. I., and Clark, B. F. (1996) Intracellular protein synthesis, modification and aging. Biochem. Soc. Trans. 24, 1043-1049
22. Ding, Q., Markesbery, W. R., Chen, Q., Li, F., and Keller, J. N. (2005) Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci. 25, 9171-9175
23. Keller, J. N., Hanni, K. B., and Markesbery, W. R. (1999) 4-hydroxynonenal increases neuronal susceptibility to oxidative stress. J. Neurosci. Res. 58, 823-830
24. Keller, J. N., Hanni, K. B., and Markesbery, W. R. (1999) Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases. J. Neurochem. 72, 2601-2609
25. Aloni, R., Peleg, D., and Meyuhas, O. (1992) Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver. Mol. Cell. Biol. 12, 2203-2212
26. Cosgrove, J. W., and Rapoport, S. I. (1986) Preparation of a cell-free extract from rat brain which can initiate protein synthesis in vitro. Neurochem. Res. 11, 1289-1301
27. Qiu, J. H., Asai, A., Chi, S., Saito, N., Hamada, H., and Kirino, T. (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20, 259-265
28. Lang-Rollin, I., Vekrellis, K., Wang, Q., Rideout, H. J., and Stefanis, L. (2004) Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway. J. Neurochem. 90, 1511-1520
29. Dietrich, P., Rideout, H. J., Wang, Q., and Stefanis, L. (2003) Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons. Mol. Cell Neurosci. 24, 430-441
30. Hanna, J., Leggett, D. S., and Finley, D. (2003) Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol. Cell. Biol. 23, 9251-9261
31. Ding, Q., and Keller, J. N. (2001) Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J. Neurochem. 77, 1010-1017
32. Lang-Rollin, I., Maniati, M., Jabado, O., Vekrellis, K., Papantonis, S., Rideout, H. J., and Stefanis, L. (2005) Apoptosis and the conformational change of Bax induced by proteasomal inhibition of PC12 cells are inhibited by bcl-xL and bcl-2. Apoptosis 10, 809-820
33. Robertson, J. D., Datta, K., Biswal, S. S., and Kehrer, J. P. (1999) Heat-shock protein 70 antisense oligomers enhance proteasome inhibitor-induced apoptosis. Biochem. J. 344, 477-485
34. Ding, Q., Dimayuga, E., Markesbery, W. R., and Keller, J. N. (2004) Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures. J. Neurochem. 91, 1211-1218
35. Ding, Q., Bruce-Keller, A. J., Chen, Q., and Keller, J. N. (2004) Analysis of gene expression in neural cells subject to chronic proteasome inhibition. Free Radic. Biol. Med. 36, 445-455
36. Yew, E. H., Cheung, N. S., Choy, M. S., Qi, R. Z., Lee, A. Y., Peng, Z. F., Melendez, A. J., Mankandan, J., Koay, E. S., Chiu, L. L., Ng, W. L., Whiteman, M., Kandiah, J., and Halliwell, B. (2005) Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis. J. Neurochem. 94, 943-956
37. Ding, Q., Reinacker, K., Dimayuga, E., Nukala, V., Drake, J., Butterfield, D. A., Dunn, J.C., Martin, S., Bruce-Keller, A. J., and Keller, J. N. (2003) Role of the proteasome in protein oxidation and neural viability after low-level oxidative stress. FEBS Lett. 546, 228-232
38. Ding, Q., Lewis, J. J., Strum, K. M., Dimayuga, E., Bruce-Keller, A. J., Dunn, J. C., and Keller, J. N. (2002) Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J. Biol. Chem. 277, 13935-13942
39. Diaz-Hernandez, M., Hernandez, F., Martin-Aparicio, E., Gomez-Ramos, P., Moran, M. A., Castano, J. G., Ferrer, I., Avila, J., and Lucas, J. J. (2003) Neuronal induction of the immunoproteasome in Huntington's disease. J. Neurosci. 23, 11653-11661